Ricart et al.
2007
Technology insight: cytotoxic drug immunoconjugates for cancer therapy
Wu et al.
2005
Arming antibodies: prospects and challenges for immunoconjugates
US11718684B2
(en )
2023-08-08
Antibody binding specifically to MUC1 and use thereof
Sapra et al.
2004
Improved outcome when B-cell lymphoma is treated with combinations of immunoliposomal anticancer drugs targeted to both the CD19 and CD20 epitopes
Allen
2002
Ligand-targeted therapeutics in anticancer therapy
Weiner et al.
2000
New approaches to antibody therapy
Smaglo et al.
2014
The development of immunoconjugates for targeted cancer therapy
US8309094B2
(en )
2012-11-13
Antibody-drug conjugates
RU2427590C2
(ru )
2011-08-27
Анти-mn антитела и способы их применения
CN113423735B
(zh )
2024-02-13
抗-紧密连接蛋白抗体及其用途
Damle
2004
Tumour-targeted chemotherapy with immunoconjugates of calicheamicin
CN113784987B
(zh )
2024-09-13
靶向磷脂酰肌醇蛋白聚糖-1的高亲和力单克隆抗体和使用方法
RU2006105339A
(ru )
2006-06-27
Rg1 антитела и их применение
KR920702692A
(ko )
1992-10-06
인체 암종과 반응성인 신규 항체
HRP20150806T1
(hr )
2015-09-11
Protutijela anti-cd22, njihovi imunokonjugati kao i njihove uporabe
CA2996205A1
(en )
2017-03-23
Monoclonal antibodies specific for fibroblast growth factor receptor 4 (fgfr4) and methods of their use
CA2374398A1
(en )
2000-12-07
Immunoconjugates having high binding affinity
Zong et al.
2024
A novel bispecific antibody drug conjugate targeting HER2 and HER3 with potent therapeutic efficacy against breast cancer
JP2024525624A5
(enExample )
2025-06-23
Kitson et al.
2013
Antibody-drug conjugates (ADCs)–biotherapeutic bullets
JP2023546493A5
(enExample )
2025-10-22
Tivadar et al.
2020
Monoclonal antibody targeting sialyl-di-Lewisa–containing internalizing and noninternalizing glycoproteins with cancer immunotherapy development potential
Lambert
2010
Antibody-maytansinoid conjugates: a new strategy for the treatment of cancer
Prabhu et al.
2011
Antibody delivery of drugs and radionuclides: factors influencing clinical pharmacology
JP2025514288A5
(enExample )
2026-05-11